XML 19 R12.htm IDEA: XBRL DOCUMENT v3.19.2
Inventory
12 Months Ended
May 31, 2019
Inventory  
Inventory

6.      Inventory

Inventory is comprised of:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

Capitalized 

    

Fair value

  

  

May 31, 

    

May 31, 

 

 

cost

 

adjustment

 

 

2019

 

2018

Harvested cannabis

 

$

10,039

 

$

13,214

 

 

$

23,253

 

$

12,331

Harvested cannabis trim

 

 

2,830

 

 

2,959

 

 

 

5,789

 

 

2,277

Cannabis oil

 

 

11,300

 

 

8,301

 

 

 

19,601

 

 

6,578

Softgel capsules

 

 

422

 

 

342

 

 

 

764

 

 

 —

Distribution inventory

 

 

32,944

 

 

 —

 

 

 

32,944

 

 

 —

Other inventory items

 

 

9,178

 

 

 —

 

 

 

9,178

 

 

964

 

 

$

66,713

 

$

24,816

 

 

$

91,529

 

$

22,150

 

During the year ended May 31, 2019, the Company recorded $35,548 (2018 - $8,692) of production costs. Included in production costs for the year ended May 31, 2019 is $1,682 of cannabis oil conversion costs (2018 - $241),  $142 related to the cost of accessories (2018 - $236), and amortization of $4,133 (2018 - $1,715). The Company also included $4,723 of amortization which remains in inventory for the year ended May 31, 2019 (2018 - $978) related to capital assets utilized in production. During the year ended May 31, 2019, the Company expensed $27,724 (2018 –$10,327) of fair value adjustments on the growth its biological assets included in inventory sold.

The Company holds 6,309.9 kilograms of harvested cannabis (May 31, 2018 – 3,221.3 kgs), 1,908.0 kilograms of harvested cannabis trim (May 31, 2018 – 702.0 kgs) and 28,458.1 litres of cannabis oils or 4,949.2 kilograms equivalent in various stages of production (May 31, 2018 – 7,724.7 litres or 1,716.6 kilograms equivalent), 982.0 litres of cannabis oils used in softgel capsules or 218.2 kilograms equivalent at May 31, 2019 (May 31, 2018 – nil).